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Background: We have reported previously that overexpression of glucose-regulated protein 78 (GRP78) promotes
the invasion of hepatocellular carcinoma. However, whether GRP78 knockdown affects the extracellular matrix
degradation has not been elucidated. Here we are going to determine whether GRP78 knockdown affect the ECM
degradation and the role of MMP-2 and MMP-9 in these process in hepatocellular carcinoma cells.
Methods: Human hepatocellular carcinoma cell line SMMC7721 and HepG2 were cultured in DMEM supplemented
with 10% FBS, RT-PCR and western blot were used to detect the endogenous expression of GRP78, MMP-2, MMP-9
and TIMP-2 in SMMC7721 and HepG2. GRP78 shRNAs were transfected using lipofection2000. Transwell assay and
wound healing assay were used to analyze the invasion of each transfectant. Gelatin zymography and FITC-gelatin
degradation assay were employed to investigate the capabilities of ECM degradation of each transfectant. MTT
assay was used to determine the proliferation status. Western blot was employed to detect the expression of matrix
metalloproteinase 2(MMP-2), MMP-9, MMP-14, and tissue inhibitor of metalloproteinases 2(TIMP-2), focal adhesion
kinase (FAK), ERK1/2, JNK and Src.
Results: According to the expression levels of GRP78, MMP-2, MMP-9, MMP-14 and TIMP-1 in hepatocellular
carcinoma cell lines SMMC7721 and hepG2, we used SMMC7721 as the in vitro invasion model for further
functional analysis. Using this model, we found that GRP78 knockdown decreased the invasion of tumor cells, and
this inhibitory effect was independent of cell proliferation. In hepatocellular carcinoma cells, Grp78 knockdown
inhibited ECM degradation and the decreased activity and expression of MMP-2, but not MMP-9 contributed largely
to this impact. Further analysis revealed that the decreased activity and expression of MMP-2 is mediated by JNK.
Conclusion: Knockdown of GRP78 decreases ECM degradation, and downregulates the expression and activity of
MMP-2 and TIMP-2. These results further demonstrate that GRP78 is a potential target for inhibiting the invasion of
hepatocellular carcinoma cells.
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Hepatocellular carcinoma (HCC), also called hepatoma, is
the most frequent type of primary liver cancer and one of
the leading causes of cancer death worldwide, which
caused over 600,000 deaths per year [1]. Invasion and
metastasis are the most critical reason for the poor
prognosis of HCC patients [2].
Glucose-regulated protein 78(GRP78) is present at a
basal level in normal tissues. However it is overex-
pressed in almost all the human cancers and plays
important role in anti-apoptotic process of cancer
cells [3]. GRP78, which has been regarded as a endo-
plasmic reticulum(ER) chaperone previously, is a
multifunctional protein [4,5]. Recently, lots of data
have demonstrated that Grp78 is involved in the
regulation of invasion and metastasis of many human
cancers including breast, prostate, gastric, lung, liver
cancers [6-10]. Although we have reported that
GRP78 facilitates the invasion of hepatocellular carci-
noma cells, whether GRP78 plays a role in ECM
degradation is still not determined.
The invasion and metastasis of cancer cells is a
complex process which is mainly determined by the
following events: (1) extracellular matrix (ECM) deg-
radation, (2) the arrangement of cytoskeleton, (3) cell
polarity formation [11-13]. These processes are tightly
regulated by temporally and spatially regulated ex-
pression and activation of many signal molecules in-
cluding focal adhesion kinase (FAK), Src, c-Jun N-
terminal kinase (JNK) [14,15].
Matrix metalloproteinases (MMPs) are a family of
related zinc-dependent proteinases that degrade most
extracellular matrix [16]. So far, nearly 20 members of
the MMP family that share common structural and
functional elements have been identified [17]. Among
them, MMP-2 and MMP-9 are the most concerned
and their functions have been well-characterized.
They are believed to play important role in the inva-
sive process and high level expression or activation of
MMPs is associated with the invasion and metastasis
of cancer cells [18]. The activity of MMP-2
and MMP-9 is regulated by many factors. Recent
studies have revealed that the membrane type
metalloproteinases (MT-MMP) and the tissue inhibi-
tor of metalloproteinases (TIMP) play coordinately in
the regulation of MMPs activity. MMP-2 is activated
by complexing with MT-MMP1 (MMP14) and TIMP-
2. However, MMP-9 is activated by binding with
TIMP-1 [19-21].
In this article, we knockdown GRP78 level in hepato-
cellular carcinoma cell line SMMC7721, and explored
the effect of Grp78 knockdown on the ECM degrad-
ation and the underlying mechanism.Results
Endogenous expression of GRP78 in hepatocellular
carcinoma cells SMMC7721 and HepG2
To investigate the expression of GRP78 in hepatocellular
carcinoma cell lines, we examined GRP78 levels in
SMMC7721 and HepG2, which are two kinds of widely
used hepatocellular carcinoma cell lines, using quantita-
tive RT-PCR and western blot and the data were analyzed
by the students’ t test. The results revealed that GRP78
was expressed in both SMMC7721 and HepG2 although
with different levels. GRP78 level in SMMC7721 cells was
significantly higher than that in HepG2 cells at both the
mRNA level (p= 0.024) and the protein level (p= 0.001)
(Figure 1A and B). We also examined the MMP-2,
MMP-9, MMP-14 and TIMP-2 levels at mRNA and
protein levels. As shown in Figure 1A and B, the MMP-2,
MMP-14 and TIMP-2 levels in SMMC7721 cells were
significantly higher than in HepG2 cells (p< 0.05 at
mRNA level and p< 0.01 at protein level), however, the
difference between the expression of MMP-9 in
SMMC7721 and HepG2 was not significant at both
mRNA level and protein level (p= 0.069).
Screening the knockdown effect of GRP78-shRNAs and
establishment of cell clones that stably expressing shGRP78
Based on the expression status of GRP78, MMP-2, MMP-
9, MMP-14 and TIMP-2 in hepatocellular carcinoma cell
lines SMMC7721 and HepG2, we choose SMMC7721 to
establish the in vitro invasion model for further research.
To identify the silencing efficiencies of GRP78-shRNAs
(abbreviated as shGRP78 below), we transiently trans-
fected each shGRP78 into SMMC7721 cells, blank vector
pEGFP-N1 was transfected at the same time as control.
Three days after transfection, GFP fluorescence was
directly observed with inverted microscope (Figure 2A).
The level of GRP78 in each pool was determined by
western blot. We found that each shGRP78 downregulated
GRP78 expression with varying degrees. The shGRP78-3
downregulated Grp78 level to ~36.3% compared with
control cells, however GRP78 levels in other three
shGRP78 transfected cells were >50% compared with
control cells (Figure 2B). According to these results, we
introduced shGRP78-3 into SMMC7721 and screened the
cells that expressing GRP78 at a relative low levels. The
clones that stably expressing shGRP78-3 were selected
by adding G418(400 μg/ml) in the culture medium for
2–3 weeks. Four clones were randomly chosen and the
expressions of GRP78 were detected by western blot
(Figure 2C). In the 4 chosen clones, GRP78 levels in clone
3 (abbreviated as C3 below) was ~39.5% of that in control
cells, the clone 4 (abbreviated as C3 below) was ~32.7%
of that in control cells. So we choose C3 and C4 for
further functional analysis. To confirm the specificity of
Figure 1 Endogenous expression of GRP78 in hepatocellular carcinoma cells. (A) Quantative RT-PCR analysis for mRNA levels of GRP78,
MMP-2, MMP-9, MMP-14, and TIMP-2 in hepatocellular carcinoma cell lines SMMC7721 and HepG2. The mRNA contents in the cells were
presented as the relative levels normalized to 18 S mRNA. (B) Western blot analysis for protein levels of GRP78, MMP-2, MMP-9, MMP-14, and
TIMP-2 in hepatocellular carcinoma cell lines SMMC7721 and HepG2. Protein levels were expressed as the ratio of target protein over β-actin. All
the experiments were repeated for three times, the values were presented as x± SE and analyzed by the students’ t-test. (Columns,mean of three
separate experiments; bars, SE; *, values significantly different at the 5% levels).
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and C4. The results revealed that transfection of
shGRP78-3 did not affect the expression of GRP94
(Figure 2D).GRP78-silencing decreased the invasion and metastasis of
SMMC-7721
To explore whether GRP78 knockdown affects the inva-
sion of HCC, we examined the invasion and motility
potentialities by Transwell assay and wounding healingassay in SMMC7721 cells. Transwell assay showed that
the number of invaded cells was equivalent to ~45.7% of
control cells in the cells of C3 and ~34.8% in C4.
These values were analyzed by one-way ANOVA and the
statistical analysis revealed that these differences were
significant(p< 0.05). These results suggested that GRP78
knockdown significantly inhibited the invasion of hepato-
cellular carcinoma cells(p< 0.05) (Figure 3A, B). Wound
healing assay showed that the motility of C3 and C4 cells
was significantly decreased as compared with control cells.
The wound closure ratio was 48% for control cells, 18%
Figure 2 Screening of the effect of GRP78-shRNAs and the establishment of cell clones that stably expressing GRP78-shRNA. (A)
Fluorescence observation of the transfection efficiencies of shGRP78s in SMMC7721 cells. ShGRP78s containing GFP tag were introduced into
SMMC7721 cells as described under “materials and methods”. After 72 h, GFP fluorescence were observed by inverted fluorescent microscope
(scale bar:25 μm). (B) Western blot analysis of GRP78 levels in GRP78-shRNAs transiently transfected cells. The GRP78 levels were presented as the
ratio of GRP78 to β-actin. (C) Western blot analysis of GRP78 levels in cells that stably expressing shGRP78-3. The contents of GRP78 were
expressed as the ratio of GRP78 toβ-actin. (D) Western blot analysis of GRP94 levels in clone C3 and C4 that stably expressing shGRP-3. The
contents of GRP94 were expressed as the ratio of GRP94 to β-actin. All the experiments were repeated for three times, the values were presented
as x± SE and analyzed by One-Way ANOVA (Columns,mean of three separate experiments; bars, SE; *, values significantly different at the 5%
levels).
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of one-way ANOVA revealed that the differences of these
values were significant(p< 0.01) (Figure 3C, D).In order to exclude the possibility that the inhibiton
of the invasion and metastasis of GRP78 knockdown
were caused by cell proliferation, we examined the
Figure 3 GRP78 silencing inhibited the invasion and metastasis of SMMC7721. (A) Transwell analysis of the invasion capability of the cells
that stably expressing shGRP78-3. The invaded cells were stained with Hochest33258 and observed using inverted fluorescent microscope, three
fields were randomly chosen and the invasion capabilities of tumor cells were represented as the numbers of the invaded cells per field (scale
bar: 25 μm). The experiments were repeated for three times. (B) Quantitative analysis of the invasive status of the cells that stably expressing
shGRP78-3. The values were presented as x± SE and analyzed by one-way ANOVA; (Columns,mean of three separate experiments; bars, SE; *,
values significantly different at the 5% levels). (C) Wound healing analysis of the metastasis of the cells that stably expressing shGRP78-3. The
confluent cells were wounded by sterile pipettes and the status of wound closure were observed and photographed after 24 h.the experiment
was repeated for three times. (scale bar: 25 μm) (D) Quantitative analysis of the metastasis status of the cells that stably expressing shGRP78-3.
The values were presented as x± SE and analyzed by one-way ANOVA; (Columns,mean of three separate experiments; bars, SE; *, values
significantly different at the 5% levels). (E) MTT analysis of the proliferation status of the cells that stably expressing shGRP78-3, the experiment
was repeated for 3 times in tripilicate and The values were presented as x± SE and analyzed by one-way ANOVA; (Columns,mean of three
separate experiments; bars, SE; *, values significantly different at the 5% levels).
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Compared with control cells and parental cells, GRP78
knockdown do not affect the proliferation of SMMC7721
in 24 h, indicating that the inhibitory effect of Grp78
knockdown on the invasion and metastasis was not
caused by cell proliferation (Figure 3E).GRP78 knockdown decreased ECM degradation
To explore whether GRP78 knockdown influences extra-
cellular matrix degradation, we applied FITC-gelatin
degradation assay to access the matrix degradation status
of parental, vector transfected, C3 and C4 cells. We
observed the FITC-gelatin degradation sites which appear
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and vector transfected cells. However, no obvious degra-
dation sites were seen in C3 and C4 cells, indicating that
GRP78 knockdown decreased the ability of ECM degra-
dation in SMMC7721 cells (Figure 4A). For the activity
and expression of Metalloproteinase (MMPs) and tissueFigure 4 GRP78 knockdown decreased ECM degradation. (A) FITC-gela
capability of the cells that stably expressing shGRP78-3. The experiments w
9,MMP-14 and TIMP-2 expression in the cells that stably expressing shGRP7
and analyzed by one-way ANOVA (Columns,mean of three separate experim
(D) Gelatin zymograph analysis of the activities of MMP-2 and MMP-9 in GR
represented as x± SE and analyzed by one-way ANOVA (Columns,mean of
the 5% levels).inhibitors of metalloproteinase (TIMPs) play critical roles
in the ECM degradation [17], we detected the expression
of MMP-2, 9, 14 and TIMP-2 in C3 and C4 cells by
western blot. The results showed that transfection of
shGRP78-3downregulated the expression levels of MMP-2,
MMP-9, MMP-14 as well as TIMP-2 compared withtin degradation analysis of the extracellular matrix degradation
ere repeated for three times. (B) Western blot analysis of MMP-2,MMP-
8-3, and the results of quantative analysis were represented as x± SE
ents; bars, SE; *, values significantly different at the 5% levels). (C) and
P78 knockdown cells. The activities of MMP-2 and MMP-9 were
three separate experiments; bars, SE; *, values significantly different at
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way ANOVA and the differences between the cells that sta-
bly expressing shGRP78-3 and control cells were significant
(p< 0.05), suggesting that GRP78 knockdown decreased
the expression levels of MMP-2, MMP-9, MMP-14 and
TIMP-2 in SMMC7721 cells (Figure 4B and 4C). We
further analyzed whether Grp78 knockdown affected the
activity of MMP2 and MMP9 by gelatin-zymography assay.
As shown in Figure 4D and 4E, the activity of MMP-2 in C3
and C4 cells was significantly lower than that in parental
and vector transfected cells, The absorptance values were
analyzed by one-way ANOVA and the differences between
the cells that stably expressing shGRP78-3 and control cells
were significant (p< 0.05). However, we do not detect the
activity of MMP-9 in parental, vector, C3 and C4 cells.
Taken together, our findings demonstrate that GRP78
knockdown inhibites the ECM degradation by decreasing
the expression and activity of MMP-2.
GRP78 knockdown decreased JNK and ERK signaling
pathway
We then sought to determine the mechanisms underlying
the reduction of MMPs activities caused by GRP78 knock-
down in SMMC7721 cells. For the important roles of
ERK1/2 and JNK in the regulation of MMP-2 and MMP-9
activities, we examined the phosphorylation levels of
ERK1/2 and JNK in C3 and C4 cells using western blot.
As shown in Figure 5A and B, the p-ERK1/2 and p-JNK
levels were reduced as compared with control cells. The
values were analyzed by one-way ANOVA and the differ-
ences between C3 or C4 cells and control cells were sig-
nificant (p< 0.05). Because the activities of ERK1/2 and
JNK were modulated in large part by FAK-Src signaling
pathway [22], we examined the phosphorylation levels of
FAK at Y397 and Src at Y416 in C3 and C4 cells. We
found that GRP78 knockdown significantly decreased the
levels of pY397-FAK and pY416-Src in SMMC7721 cells
(p< 0.05) (Figure 5C). These data indicate that decreased
ERK1/2 and JNK activities are involved in reducing MMP-
2 activities triggered by GRP78 knockdown.
JNK signaling is involved in the reduced MMP-2 activity
caused by GRP78 Knockdown
To explore the signaling pathway involved in the reduc-
tion of MMP-2 activity induced by GRP78 knockdown,
we inhibited the activity of JNK using SP600125, an in-
hibitor of JNK at various concentrations ranging from 5 to
15 μM in the cells that overexpressing wild type GRP78
which were established by our laboratory previously [9].
We found that the activity of MMP-2 gradually decreased
with the increase of the concentration of SP600125. When
the concentration rose to 15 μM, the activity of MMP-2
was almost not detected (Figure 6A and 6B). These data
suggested that JNK is involved in the regulation of MMP-2activity in GRP78 knockdown cells. To further confirm the
roles of JNK in GRP78 knockdown induced reduction
of MMP-2 activity, we examined the phosphorylation of c-
Jun, which plays critical roles in the regulation of MMP-2
expression and activity. As shown in Figure 6C and 6D,
GRP78 knockdown markedly reduced the phosphorylation
level of c-Jun and the one-way ANOVA analysis revealed
that the differences between C3 or C4 and control cells is
significant (p< 0.05). Taken together; these data suggested
that JNK is involved in the reduced MMP2 activity caused
by GRP78 knockdown.
Discussion
In this study, we show that knockdown of GRP78 reduces
the invasiveness and metastasis in hepatocellular carcino-
ma cells SMMC7721, and we identify a molecular mech-
anism involving FAK-Src-JNK-c-Jun-MMP2 signaling
pathway in these effects. These data point to a potential
antitumor target for GRP78 in hepatocellular carcinoma
cells.
We choose hepatocellular carcinoma cell line
SMMC7721 for the establishment of in vitro invasion and
metastasis model according to the expression levels of
GRP78, MMP-2, MMP-9, MMP-14 and TIMP-2. We first
demonstrate that knockdown of GRP78 inhibited the
invasion and metastasis in SMMC7721. Many data have
revealed that cell proliferation affected the outcomes of
both transwell assay and wound healing assay, it is
essential to examine whether GRP78 knockdown affected
the proliferation of SMMC7721. In our research, we
demonstrated that GRP78 knockdown do not have
influence on tumor cells at the first 24 h. Taken together,
these results suggested that knockdown of GRP78
decreased the invasion and metastasis of SMMC7721 and
this inhibitory effect was not dependent on the prolifera-
tion of tumor cells.
Abnormal expression of MMPs is believed to play an
important role in tumor cell invasion and metastasis in
human cancers, including hepatocellular carcinoma [23].
Among the MMPs, the roles of MMP-2 and MMP-9 in
the invasiveness and metastasis of cancer cells are
well characterized. In our study, we show that GRP78
knockdown reduced the expression and activity of MMP-
2 in SMMC7721 cells. Although we detected MMP-9
expression by RT-PCR and western blot, we do not detect
the secretion and activity of MMP-9 in SMMC7721. To
elucidated this question, we examined the activities of
MMP-9 in four hepatocellular carcinoma tissue samples
by gelatin zymograph assay. MMP9 activities can be
detected in all the four tissue samples. Since tissue sam-
ples are composed of cancer cells and surrounding non-
cancer cells,which is the components of tumor micro-
environment, we think that MMP-9 is secreted mainly by
the non-cancer cell in tumor microenvironment.
Figure 5 GRP78 knockdown decreased JNK and ERK signaling pathway. (A) Western blot analysis of JNK and p-JNK levels in cells that stably
expressing shGRP78-3. (B) Western blot analysis of the ERK and p-ERK levels in cells that stably expressing shGRP78-3. (C) Western blot analysis of
FAK, pY397-FAK, Src and pY416-Src in the cells that stably expressing shGRP78-3. All the experiments were repeated for three times, the results of
quantative analysis were represented as x± SE and analyzed by one-way ANOVA. (Columns,mean of three separate experiments; bars, SE; *, values
significantly different at the 5% levels).
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2 activates pro-MMP-2 by forming a complex with TIMP-2
and pro-MMP-2. We found that GRP78 knockdown
reduced the expression of MMP-14 and TIMP-2, indicating
that knockdown of GRP78 decreased the expression of the
members of the MMP-2 activating complex.In this article, we further investigate the signaling
mechanisms involved in the reduced MMP-2 and MMP-9
activities. Mitogen-activated protein kinases(MAPKs) are
key signaling molecules controlling MMPs which is modu-
lated large part by FAK-Src signaling pathway. We found
that knockdown of GRP78 decreased the phosphorylation
Figure 6 JNK signaling is involved in the reduced MMP-2 activity caused by GRP78 Knockdown. (A). Gelatin zymograph analysis of MMP-2
activity in SP600125 treated GRP78 overexpressing cells (OE). GRP78 OE cells were treated with the JNK inhibitor SP600125 at various
concentrations for 12 h, the conditioned medium were collected and the activity of MMP-2 were detected by gelatin zymograph. Schematic
diagram of the MMP-2 activities in GRP78 OE cells that treated with SP600125, the results of quantative analysis were represented as x± SE and
analyzed by one-way ANOVA. (Columns, mean of three separate experiments; bars, SE; *, values significantly different at the 5% levels). (B)
Western blot analysis of the c-Jun and p-c-Jun in the cells that stably expressing shGRP78-3 and schematic diagram of the expression levels of c-
Jun and p-c-Jun. All the experiments were repeated for three times, the results of quantative analysis were represented as x± SE and analyzed by
one-way ANOVA. (Columns, mean of three separate experiments; bars, SE; *, values significantly different at the 5% levels).
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that GRP78 knockdown downregulated the activity of
FAK and Src. AP-1 complex which consists of c-Jun
and c-fos plays important roles in several cellular pro-
cesses. AP-1 complex translocated into the nucleus
and activated the promoters containing AP-1 binding
sites including the MMP-2 promoter when c-Jun was
phosphorylated by JNK. Our finding that GRP78
knockdown decreased the phosphorylation of c-Jun
and inhibited the translocation of AP-1 complex intonucleus. These data suggested that c-Jun was the
downstream transcription factor in the reduced MMP2
activity caused by GRP78 knockdown.
Overall, our data revealed a mechanism by which
GRP78 knockdown inhibits the ECM degradation and
the activity and expression of MMP-2. JNK-c-Jun signal-
ing pathway play important role in this process. This
finding suggested that GRP78 may be a potential target
for the prevention of the invasion and metastasis of
hepatocellular carcinoma.
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Antibodies
The primary antibodies used were: GRP78 (sc-1051),
GRP94 (sc-1794), MMP-2 (CST-4022), MMP-9 (CST-
3852), MMP-14 (ab3644), TIMP-1 (CST-8946), TIMP-2
(sc-21735), FAK (396500, Biosource), FAK-pY397
(44625 G, Biosource), JNK (sc-7345), Src(CST-2123), Src-
pY416(CST-6943), p-JNK (sc-6354), c-Jun (CST-9165), p-c-
Jun (CST-9261). HRP-conjugated secondary antibodies
were purchased from Zhongshan Company (Beijing,
China).Cell culture
Human hepatocellular carcinoma cell line SMMC7721 and
HepG2 were purchased from the Type Culture Collection
of Chinese Academy of Science. The cells were propagated
in complete DMEM medium supplemented with 10% fetal
bovine serum(FBS), 2 mM glutamine, 100 U/ml penicillin,
100ug/ml streptomycin at 37°C, 5% CO2 -95% O2 and pas-
saged every 3–5 days.GRP78-shRNAs transfection into SMMC-7721
The pEGFP-N1-GRP78-shRNAs were purchased from the
Genechem Company (Shanghai, China). The sequences










Transfection was performed using Lipofectamine™
2000(Invitrogen) as the manufacture’s instruction.
Briefly, the logarithmically growing cells were plated
in 6-well plate in 2000 μl of DMEM complete growth
medium without antibiotics and with serum. After
24 h, 10 μl of Lipofectamine™ 2000 was diluted to
250 μl by serum-free medium, mixed with DNA solu-
tion (4 μg DNA in 250 μl serum-free medium) in a
sterile 1.5 ml EP tube and incubated for 30 min at
room temperature. The mixture was added drop by
drop into each well, incubated for 72 h under normal
cell culture conditions. pEGFP-N1 was transfected at
the same time as control. The transfection efficiency
was observed by fluorescent microscope and the ef-
fect of GRP78-shRNAs was determined by western
blot.Establishment of cells that stably expressing GRP78-
shRNAs
Selection of SMMC-7721 cells stably expressing GRP78-
shRNAs was performed according to the manufacturer’s
instructions (Invitrogen). Briefly, the complete growth
medium containing GRP78-shRNAs were replaced by the
selection medium containing G418 (Gibco, 400 μg/ml)
after 48 h of transfection. The selection medium was
replaced every 3–4 days, the clones that stably expressing
GRP78-shRNAs were picked, expanded, cultured in the
medium containing 200 μg/ml of G418, and identified by
western blot and RT-PCR.
RNA extraction and RT-PCR analysis
Total RNA was isolated using Trizol (Invitrogen) according
to the manufacture’s recommendation. 2 μg of total RNA
from each samples were reverse transcribed using oligo
(dT) primers at 37°C for 90 min. The relative mRNA levels
were evaluated by quantitative PCR using SYBR green
PCR kit (Takara). The signals were normalized to 18 S as









18 S Forward, 5’-TCAAGAACGAAAGTCGGAGG-3’
Reverse, 5’-GGACATCTAAGGGCATCACA-3’
Western blot-analysis
Cells were washed, harvested, lysed by lysis buffer
(150 mM NaCl, 1% NP-40, 1% SDS, 1 mM PMSF, 10ug/
ml Leupeptin, 1 mM Aprotinin,50 mM Tris-Cl, pH 7.4)
on ice for 30 min and centrifuged at 12,000 g at 4°C for
10 min. The supernatants were quantified for protein
concentration by BCA assay. Equal amounts of protein
were loaded (50 μg per lane) and separated by 10% SDS-
PAGE, transferred to PVDF membrane. The membrane
was blocked with 5% non-fat milk for 2 h, incubated with
a specific antibody (1:1000 dilution) for 3 h, stained with
appropriate secondary antibody conjugated with HRP
(1:2000 dilution) for 30 min at room temperature. After
final washes, the membrane was developed using ECL
reagent (Pierce, France). The levels of target proteins were
normalized to β-Actin.
Transwell invasion and wound healing assays
Cells were harvested and seeded onto the fibronectin-
coated, porous upper chamber inserts (105 per well) and
allowed to invade for 48 h. After 48 h, the inserts were
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were randomly chosen and the numbers of invaded cells
were counted. The invasion potentiality of the GRP78
knockdown cells was measured by the average value of
penetrated cells in three fields. For wound healing assay,
the monolayer was carefully wounded by sterile pipette
and washed with PBS for three times to remove the
debris. The wounded monolayer was cultured in DMEM
containing 1% BSA for 24 h, and photographed by micro-
scope (×100). The status of wound closure was evaluated
by inverted microscope.
Cell proliferation assay
Cells were seeded in 96-well culture plate at a density of
5 × 104/ml, 100 μl each well. The status of cell viability
were monitored every 24 h. Briefly, the cells were washed
with PBS for 3 times, 100 μl sterilized MTT solution
(0.5 mg/ml) were added into each well and the cells were
incubated for 4 h in normal culture condition. After
incubation, 100 μl DMSO were added to each well, and
the culture plate was vortexed for 2-3 min to fully dissolve
the crystallization. Finally, the absorbance at 562 nm was
measured using microplate reader.
FITC- Gelatin degradation assay
FITC-gelatin degradation assay was performed as the
manufacture’s procedure (Invitrogen). In brief, coverslips
(18-mm diameter) were coated with 50ug/ml poly-L-ly-
sine for 20 min at room temperature, washed with PBS,
fixed with 0.5% glutaraldehyde for 15 min and washed
with PBS for 3 times. After washing, the coverslips were
inverted on a drop of 0.2% FITC conjugated gelatin in
PBS containing 2% sucrose, incubated for 10 min at room
temperature, washed with PBS for 3 times, quenched with
sodium borohydride (5 mg/ml) for 3 min and finally incu-
bated in 2 ml of complete medium for 2 h. Cells (2 × 105
each well) were plated in FITC gelatin-coated coverslips,
incubated at 37°C for 12 hr. The ECM degradation status
was evaluated and photographed by inverted fluorescent
microscope.
Gelatin zymography
The Conditioned medium was collected and concentrated
for 2-fold by centrifugal concentrator. Equal amounts of
protein were loaded and separated by 10% polyacrylamide
gel containing 1 g/L gelatin. The gels were re-natured in
2.5% Triton-X-100 with gentle agitation for 30 min at
room temperature. The gel was pretreated by developing
buffer (5 mM CaCl2, 50 mM Tris, and 0.2 mM NaCl,
0.02% Brij35 (pH 7.5)) for 30 min at room temperature,
then developed in developing buffer overnight at 37°C,
stained with Coomassie Brilliant Blue R-250 for 30 min-
utes and destained with destaining solution. The protease
activity was analyzed by gel imaging and analysis system.Statistical analysis
The results were represented as x±SE. Difference between
two experimental groups was evaluated by the students’t
test and differences among groups were analyzed using
One-Way ANOVA. P< 0.05 was considered to be statisti-
cally significant.
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